Hydralid 25 Tablet contains Hydralazine 25 mg, an antihypertensive medicine used for the management of high blood pressure and certain cardiovascular conditions. It works by relaxing and widening blood vessels, allowing blood to flow more easily throughout the body. This action helps reduce elevated blood pressure levels and decreases the workload on the heart, supporting overall cardiovascular health and circulation.
Hydralazine belongs to the vasodilator class of medicines and exerts its therapeutic effect by directly acting on the smooth muscles of blood vessels. By reducing vascular resistance, it helps improve blood flow and lower blood pressure effectively. The medicine is often prescribed as part of a comprehensive treatment plan that may include other cardiovascular medications, dietary modifications, and lifestyle changes to achieve optimal blood pressure control.
The tablet is commonly indicated for hypertension and may also be used in selected cardiovascular conditions as determined by a healthcare professional. Effective blood pressure management helps reduce the risk of serious complications such as stroke, heart attack, heart failure, and kidney damage. Regular use as prescribed, along with routine monitoring, contributes to better long-term cardiovascular outcomes and improved patient well-being.
With the increasing prevalence of hypertension and cardiovascular disorders, Hydralid 25 Tablet continues to maintain strong demand in the cardiology segment. Its established clinical use, physician acceptance, and importance in blood pressure management contribute to consistent market potential. The product offers valuable business opportunities and sustainable growth prospects for retailers and distributors operating within the cardiovascular pharmaceutical sector.